HomeREGULATORY
REGULATORY

Chuikyo Supports Price Raise Rules for Cost-Effective Products
(Nov.8.2018)

Keiko Morimitsu, Director, Medical Economics Division, Health Insurance Bureau, MHLW
A key health ministry reimbursement panel on November 7 discussed how to raise prices for drugs and medical devices deemed cost-effective under an envisioned full-scale cost-effective assessment (CEA) scheme, with members supporting rules adopted in its pilot CEA program ...
(LOG IN FOR FULL STORY)